Current landscape of SARS-CoV-2 variants, disease, immunisation and monoclonal antibodies in Australia
In this symposium, we review the effect of vaccinations and booster doses on severe COVID-19 disease presentations to Australian hospitals in the era of Delta and Omicron variants. We then investigate the antibody characteristics following SARS-CoV-2 vaccination and their activity against variants, and how that framework applies to the development of therapeutic antibody treatments. Speakers: Professor Robert Booy and Dr Alberto Stella